Clinical Trial Update: Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III) [Phase 3]

View source ↗

Summary

Phase III trial comparing immune equivalence and overall safety between multi-dose and single-dose Vi-DT typhoid vaccine formulations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid Fever

Drugs mentioned

• Vi-DT (typhoid conjugate vaccine Vi-DT)

Snippet

Sponsor: International Vaccine Institute | Conditions: Typhoid | Phase 3 | Status: COMPLETED